title: Termination of refractory focal status epilepticus by the P-glycoprotein inhibitor verapamil.
authors.forename: S
authors.initials: S
authors.lastname: Pirker
authors.forename: C
authors.initials: C
authors.lastname: Baumgartner
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000037:antagonists & inhibitors*; D000369:Aged, 80 and over; D000927:Anticonvulsants / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000150:complications / Q000188:drug therapy; D003704:Dementia / Q000150:complications; D004074:Digitoxin / Q000627:therapeutic use; D004351:Drug Resistance / Q000187:drug effects*; D004359:Drug Therapy, Combination; D020938:Epilepsy, Partial, Motor / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006801:Humans; D020244:Infarction, Middle Cerebral Artery / Q000150:complications*; D020762:Infarction, Posterior Cerebral Artery / Q000150:complications*; D007676:Kidney Failure, Chronic / Q000150:complications; D013226:Status Epilepticus / Q000188:drug therapy* / Q000209:etiology; D014700:Verapamil / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000927:Anticonvulsants; D014700:Verapamil; D004074:Digitoxin; D001241:Aspirin